The Brain Health Red Flag That Shows Up in the Shower
We live in our own heads every day. Yet, recognizing signs that something is up with our brain health is challenging. In fact, someone's family and friends often express concerns about cognitive decline before they do.Still, it's essential to be aware of red flags that indicate trouble with memory. Some can occur in personal settings, like the shower. No one else knows how often you shampoo or whether you apply body wash or cleanser first."Being aware of changes in brain health can help catch early warning signs of conditions like Alzheimer's disease and other memory disorders," explains Dr. Joel Salinas, MD, the co-founder and chief medical officer of Isaac Health. "The earlier we recognize these changes, the more we can do to support brain function, slow progression and plan for the future. Brain health is just as important as heart health or mental health—and just as worth protecting and prioritizing."One way to monitor your brain health is to recognize subtle signs of cognitive decline, such as this early flag that begins in the shower.🩺 💊
Skipping one or more of your normal shower routine steps, such as washing your face or hair, may be a symptom of cognitive decline."Forgetting parts of your usual shower routine, like using conditioner, can be a sign that your memory or focus isn't working as well as usual," reports Dr. Sanam Hafeez, Ph.D., a neuropsychologist and the director of Comprehend the Mind. "These small changes might seem harmless but could point to early brain health issues. When your brain struggles to remember everyday tasks, it may mean something deeper is going on."For many, a shower routine is almost automatic, like brushing your teeth (unsurprisingly, recent research indicates that poor oral hygiene is also linked to cognitive issues). So, when you constantly forget your daily dose of shampoo, it's cause for concern.
"Our brains thrive on routine," Dr. Salinas says. "When someone starts skipping steps in a habit they've done for years—like forgetting to use conditioner or not rinsing off—it could be a subtle sign of trouble with memory, focus or mental organization."Believe it or not, the brain has a lot to organize when you run through your shower steps."They require the interplay of multiple cognitive domains, like memory, planning, sequencing, judgment and physical coordination," explains Dr. Adel Aziz, MD, a neurologist with JFK University Medical Center.
Dr. Aziz says that difficulty with routine tasks suggests a possible breakdown in these processes, potentially cognitive decline.
Related:
You may be wracking your brain trying to remember whether you applied lotion, as you usually do, in the shower. The struggle to remember may also throw you for a loop—is something wrong? Experts stress that even if you occasionally forget a shower step (or where you put your phone), it's not necessarily a red flag for brain health. "Occasional forgetfulness—such as misplacing keys or temporarily forgetting a name or getting distracted from a task—can happen to older individuals, especially if they get tired, are multitasking or are overwhelmed," Dr. Aziz emphasizes.Dr. Hafeez agrees—who doesn't forget things when they're tired or stressed? "If it starts happening often, it could be a red flag," she explains. "Repeatedly forgetting basic steps in your daily routine may point to changes in your brain. It's especially concerning if others notice or if it begins to affect your daily life."
However, another expert also wants family members and friends to understand that some people may be making personal (lifestyle) choices. "It's a matter of degree," says Dr. John Showalter, MD, MSIS, a board-certified internal medicine and informatics specialist and the chief operating officer of Linus Health. "A new retiree who decided he no longer wants to shave every day is not concerning. If the same retiree doesn't shower for a week or stops getting haircuts because he no longer seems to care about his personal appearance, that can be an indicator of [mild cognitive impairment] and requires follow-up with a medical professional."Related:
Forgetting steps in the shower repeatedly is only one symptom of cognitive decline. Dr. Aziz also suggests that people be aware of the following other red flags:
Forgetting things often or struggling to retain new information ("This can manifest as repeatedly asking the same questions," Dr. Aziz says.)
Inability to perform familiar tasks, like getting dressed or meal preparation
Family and friends voice concerns
Putting items in unusual or illogical places
Making poor decisions, including neglecting personal safety
Rapid mood swings
Withdrawal
Suspicion
Aggression
Brief confusion about the day or week before quickly realizing the accurate date
Getting lost in unfamiliar places but can figure out how to get back
Getting lost in familiar places, like the supermarket
Confusion about time, place and identity
Losing track of the date, season or passage of time
Related:
Experts recommend expressing concerns about cognitive decline to a primary care doctor first."The doctor can do a basic checkup and may run tests to rule out other causes like vitamin deficiencies or medication side effects," Dr. Hafeez says. "If needed, they may refer the person to a neurologist specializing in brain health. A neurologist can do more detailed tests to understand what's going on."
She explains that early detection can also help improve a person's quality of life, sharing, "Seeing a doctor early is important because some causes of memory problems can be treated. It also helps create a care plan if a long-term condition is found."
Dr. Aziz says a care plan for cognitive decline might include lifestyle tweaks like:
Regular exercise
Eating nourishing foods, like the ones included in the Mediterranean Diet and MIND Diet
Developing new skills and pursuing hobbies that keep the mind engaged
Engaging with families and friends
Getting enough sleep
Limiting or eliminating alcohol intake
Family and friends can also help in these efforts and others."For caregivers, providing written instructions for care and breaking down complex tasks into simpler, manageable steps can facilitate daily activities," Dr. Aziz says. "Creating a comfortable, safe and reassuring environment for activities like bathing can reduce anxiety and resistance. Encouraging participation and offering limited choices can help individuals maintain a sense of control and dignity."
Up Next:Dr. Joel Salinas, MD, the co-founder and chief medical officer of Isaac Health
Dr. Sanam Hafeez, Ph.D., a neuropsychologist and the director of Comprehend the Mind
Dr. Adel Aziz, MD, a neurologist with JFK University Medical Center
Improving oral hygiene for better cognitive health: Interrelationships of oral hygiene habits, oral health status, and cognitive function in older adults. JAN.
Dr. John Showalter, MD, MSIS, a board-certified internal medicine and informatics specialist and the chief operating officer of Linus Health
The Brain Health Red Flag That Shows Up in the Shower first appeared on Parade on Jul 9, 2025
This story was originally reported by Parade on Jul 9, 2025, where it first appeared.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Market Surges Amid Rising Liver Disease and Cancer Prevalence
The global ascites market is experiencing significant growth, driven by the rising prevalence of liver diseases, cancers, and other risk factors like alcohol consumption and hepatitis infections. Key advancements in diagnostic technologies, such as ultrasound and CT scans, are enhancing early detection and treatment options. Despite growth, challenges like high treatment costs and potential side effects hinder market expansion, particularly in developing regions. Leading companies, including Ocelot Bio and Regeneron Pharmaceuticals, are innovating to improve treatment efficacy. With increasing demand in emerging markets and an aging population, the ascites market is set for sustained growth. Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Ascites Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has been added to ascites market is witnessing substantial growth, driven by a range of key factors. One of the primary drivers for the ascites market is the rising prevalence of liver diseases, particularly cirrhosis, as well as various forms of cancer, such as liver, ovarian, and pancreatic cancer. As these diseases are among the leading causes of ascites, their increasing incidence globally is driving the demand for diagnostic tools and treatment options. The global rise in lifestyle diseases, alcohol consumption, and hepatitis infections has contributed to this increase, which in turn propels the growth of the ascites market. As the ascites market continues to evolve, several emerging trends are expected to significantly influence its future trajectory. The aging global population is another significant factor driving the ascites market. Older adults are more prone to liver diseases, heart failure, and cancer, all of which are major risk factors for ascites. As the number of elderly individuals increases, the prevalence of ascites is expected to rise, further driving the demand for effective treatments and management strategies. Leading players in the global ascites market, such as Ocelot Bio, Regeneron Pharmaceuticals, and BioVie Inc., are continuously focusing on several strategies to maintain their competitive edge and drive growth. These strategies include continuous technological innovation, such as the development of more advanced and efficient treatment options, mapping systems, and imaging technologies. These companies aim to enhance the safety and efficacy of ascites treatment competitive landscape of the global ascites market is diverse, with numerous players across different regions offering a wide range of products. Regional players and local manufacturers are expected to play an important role in the market's growth, especially as demand increases in emerging markets such as Asia-Pacific and Latin America. As consumer preferences shift towards more discreet, comfortable, and affordable solutions, the ascites market will continue to evolve, fostering new opportunities for both established and emerging the development and improvement of diagnostic technologies, including imaging techniques like ultrasound, CT scans, and the use of paracentesis for fluid analysis, are major drivers for the ascites market. Early detection and accurate diagnosis allow for timely intervention, improving treatment outcomes. The availability of non-invasive and highly sensitive diagnostic tests increases the likelihood of diagnosing ascites in its early stages, expanding the demand for related treatment and management the positive growth trajectory, several challenges continue to impact the global ascites market. One of the primary challenges is the high cost of treatments, particularly for advanced interventions such as liver transplants, chemotherapy, and some novel drug therapies. These costs can be a significant barrier to access, especially in developing regions where healthcare infrastructure may be limited, and insurance coverage for expensive treatments may not be available. This high cost can restrict the market growth, as many patients may not be able to afford the necessary side effects and complications of treatment further restrict the market growth. Several treatments for ascites, including diuretics and paracentesis, can lead to complications or side effects, such as electrolyte imbalances, infections, or low blood pressure. These potential risks may deter patients from seeking treatment or adhering to prescribed regimens, thus limiting the overall demand for these interventions. Additionally, the invasive nature of some treatments, such as the need for repeated paracentesis, can be uncomfortable for patients and may result in decreased willingness to pursue these conclusion, the global ascites market is expected to see steady growth, driven by the increasing prevalence of underlying conditions such as liver diseases and cancers, as well as advancements in diagnostic and therapeutic options. Continued research and innovation in targeted treatments, along with a growing focus on early detection, will be key to improving patient outcomes and reducing the burden of ascites on healthcare systems. As stakeholders, including pharmaceutical companies, healthcare providers, and researchers, continue to work toward better management strategies, the market will evolve to offer more effective solutions, ultimately enhancing the quality of life for patients and addressing the ongoing challenges posed by this Topics Covered: 1. Global Ascites Markets: Industry Outlook1.1 Introduction1.2 Market Trends1.3 Regulatory Framework1.4 Epidemiology of Ascites1.5 Clinical Trial Analysis1.6 Market Dynamics1.6.1 Impact Analysis1.6.2 Market Drivers1.6.3 Market Challenges1.6.4 Market Opportunities2. Global Ascites Market, by Region, $Million, 2023-20352.1 North America2.1.1 Key Findings2.1.2 Market Dynamics2.1.3 Market Sizing and Forecast2.1.3.1 North America Ascites Market, by Country2.1.3.1.1 U.S.2.2 Europe2.2.1 Key Findings2.2.2 Market Dynamics2.2.3 Market Sizing and Forecast2.2.3.1 Europe Ascites Market, by Country2.2.3.1.1 Germany2.2.3.1.2 U.K.2.2.3.1.3 France2.2.3.1.4 Italy2.2.3.1.5 Spain2.3 Asia Pacific2.3.1 Key Findings2.3.2 Market Dynamics2.3.3 Market Sizing and Forecast2.3.3.1 Asia Pacific Ascites Market, by Country2.3.3.1.1 Japan3. Global Ascites Market: Competitive Landscape and Company Profiles3.1 Key Development and Strategies3.1.1 Mergers and Acquisitions3.1.2 Synergistic Activities3.1.3 Business Expansions and Funding3.1.4 Product Launches and Approvals3.1.5 Other Activities3.2 Company Profiles3.2.1 Ocelot Bio3.2.1.1 Overview3.2.1.2 Top Products / Product Portfolio3.2.1.3 Target Customers/End-Users3.2.1.4 Key Personnel3.2.1.5 Analyst View3.2.2 PharmaIN3.2.3 Grifols Therapeutics LLC.3.2.4 Regeneron Pharmaceuticals.3.2.5 BioVie Inc4. Research Methodology For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
32 minutes ago
- Yahoo
Exact Sciences Schedules Second Quarter 2025 Earnings Call
MADISON, Wis., July 14, 2025--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its second quarter 2025 financial results after the close of the U.S. financial markets on August 6, 2025. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress. Second quarter 2025 webcast & conference call details Date: Wednesday, August 6, 2025 Time: 5 p.m. ET Webcast: The live webcast can be accessed at Telephone: Domestic callers, dial 888-330-2384International callers, dial +1 240-789-2701 Access code for both domestic and international callers: 4437608 A replay of the webcast will be available at The webcast, conference call, and replay are open to all interested parties. About Exact Sciences Corp. A leading provider of cancer screening and diagnostic tests, Exact Sciences helps patients and health care providers make timely, informed decisions before, during, and after a cancer diagnosis. The company's growing portfolio includes well-established brands such as Cologuard® and Oncotype DX®, along with innovative solutions like Oncodetect™ for molecular residual disease and recurrence monitoring. Exact Sciences continues to invest in a robust pipeline of advanced cancer diagnostics aimed at improving outcomes. For more information, visit follow @ExactSciences on X, or connect on LinkedIn and Facebook. View source version on Contacts Investor Contact:Derek Leckow608-893-0009investorrelations@ 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤


Medscape
43 minutes ago
- Medscape
ACG Refreshes Preventive Care in IBD Guidance
The American College of Gastroenterology has issued an updated clinical practice guideline on preventive care for patients with inflammatory bowel disease (IBD) that covers vaccinations, cancer surveillance, bone health monitoring, lifestyle counseling, and other important 'health maintenance' issues. 'Patients with IBD often consider their gastroenterologist to be the primary provider of care. Because more than 70% of patients with IBD will at some time be on medications that will affect the immune system, it is essential that the gastroenterology team promote vaccinations and other health maintenance activities,' said the writing group, led by Francis Farraye, MD, director, Inflammatory Bowel Disease Center, Mayo Clinic, Jacksonville, Florida. The panel noted that referral to dermatology, endocrinology, gynecology, primary care, and psychiatry 'may be necessary on a case-by-case basis. Coordination between the gastroenterology team and other providers is crucial for improving the quality of care that we provide to our patients living with IBD.' The 27-page updated guideline on preventive care in IBD was published earlier this month in The American Journal of Gastroenterology , along with a one-page visual highlights summary. The update provides 12 recommendation statements and 11 key concepts. It replaces the 2017 ACG guideline on preventive care in IBD. Prioritize Vaccinations 'Patients with IBD are at increased risk for infections as a consequence of their disease, and this risk may be amplified by certain immune-modifying therapies,' the writing group noted. They strongly recommend that all adults with IBD aged 50 years and older with no prior pneumococcal vaccination receive the pneumococcal conjugate vaccine (PCV) 20 or PCV21. There is a conditional recommendation that adults aged 19-49 years on immune-modifying therapy and with no prior pneumococcal vaccination also receive the PCV20 or PCV21 vaccine. Patients with IBD who previously received a pneumococcal vaccine should follow revaccination advice from the CDC. Vaccination against herpes zoster with the two-dose inactive recombinant herpes zoster vaccine is advised for patients with IBD aged 50 years or more and for younger patients about to start or already on immune-modifying therapy (both conditional recommendations). Other conditional recommendations include vaccination against SARS-CoV-2 in accordance with national guidelines and live rotavirus vaccine for children with in-utero exposure to biologics. In addition, all adults with IBD should receive annual influenza vaccines; those receiving immune-modifying therapies and their household contacts should receive the nonlive trivalent inactivated influenza vaccine but not the live inhaled influenza vaccine. Respiratory syncytial virus (RSV) vaccine is advised for all patients aged 75 and older and for those aged 50-74 years with certain chronic medical conditions or other risk factors for severe RSV disease. Household members of patients receiving immune-modifying therapies can receive live vaccines with certain precautions. Vaccinations against tetanus, diphtheria, and pertussis (Tdap), hepatitis A virus, human papillomavirus (HPV), and meningococcus should be administered according to CDC recommendations. Adults with IBD should receive vaccination against hepatitis B if not immune. Skin and Cervical Cancer Surveillance 'In addition to vaccination issues, it is important to identify subgroups of patients with IBD that have an increased risk of developing cervical cancer, nonmelanoma skin cancer (NMSC), and melanoma,' the panel said. In women with IBD on immune-modifying therapies, there is a conditional recommendation for annual cervical cancer screening within a year of sexual activity onset; in women younger than 30 years, screening should continue for 3 consecutive years before increasing to every 3 years. Annual screening for melanoma (independent of biologic therapy) and for NMSC (particularly in adults aged 50+) is also suggested (conditional recommendations). Bone and Mental Health Patients with IBD are at increased risk for bone loss, which can lead to osteopenia and osteoporosis. The guideline suggests screening for osteoporosis with bone mineral density testing at the time of diagnosis and periodically after diagnosis (conditional recommendation). Given data showing worse outcomes among smokers with IBD, smoking cessation counseling is strongly encouraged. The guideline also addresses the mental health of patients with IBD. 'Current evidence suggests that mood disorders, in particular depression and anxiety, are more prevalent in patients with IBD than the background population, the panel noted. Therefore, they recommend that all patients with IBD be screened for depression and anxiety at baseline and annually. Patients who screen positive for anxiety and/or depression should be referred for counseling/therapy.